echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > "Immunity" new findings on B cells may improve vaccine design

    "Immunity" new findings on B cells may improve vaccine design

    • Last Update: 2021-09-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Picture: Vassilis Gleros (left), Taras Kreslavsky and Sebastian Ols (right) at Solna School of Medicine, Karolinska Institute, Sweden



    Our body can fine-tune the immune system's response to infection so that it is directly proportional to the immediate threat


    An effective immune response to infections and vaccines requires antibodies, which are produced by specific effector B cells of the immune system


    Early wave of memory cells

    In a new study, researchers at Karolinska Institute studied the formation of B cells in the early stages of infection and vaccination in animal models


    "We found that there is a broad wave of early memory cells, which seems to be the'default' fate of many activated B cells, and these early memory cells seem to live as long as the traditional late memory cell wave


    Can improve vaccine design

    The research team also found that the early memory response is evolutionarily conservative, so it is possible to affect the body's B cell response through vaccination


    "We believe that reasonable vaccine design may make it possible to manipulate the B cell types that are formed, thereby making the body's defenses more effective," said Vassilis Glaros, the first author of the study and a PhD student in Taras Kreslavsky's research group


    The researchers plan to further study how the early B cell response is regulated and the consequences of distorting the response between the fate of effector cells and memory cells


    Vital to our body’s defenses

    "Memory B cells are essential for our body to resist evolving pathogens, such as the SARS-CoV-2 virus mutation that causes COVID-19," Sebastian Ols said


    "Limited access to antigen drives generation of early B cell memory while restraining the plasmablast response" .


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.